THE Therapeutic Goods Administration has updated its list of designated orphan drugs, with the addition of Phenasen (arsenic trioxide) for the treatment of Acute Promyelocytic Laukaemia; and Raxone (idebenone) for Duchenne muscular dystrophy.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Mar 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Mar 17